NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma

被引：0
|
作者：
Andrew Menzies-Gow
Gene Colice
Janet M. Griffiths
Gun Almqvist
Sandhia Ponnarambil
Primal Kaur
Gennaro Ruberto
Karin Bowen
Åsa Hellqvist
May Mo
Esther Garcia Gil
机构：
[1] Royal Brompton Hospital,Late Respiratory & Immunology
[2] BioPharmaceuticals R&D,Translational Science and Experimental Medicine, Early Respiratory & Immunology
[3] AstraZeneca,Late Respiratory & Immunology
[4] BioPharmaceuticals R&D,Late Respiratory & Immunology
[5] AstraZeneca,BioPharma Study Management, Late Respiratory & Immunology
[6] BioPharmaceuticals R&D,Biometrics, Late Respiratory & Immunology
[7] AstraZeneca,Biometrics, Late Respiratory & Immunology
[8] BioPharmaceuticals R&D,Global Medical Respiratory
[9] AstraZeneca,undefined
[10] Amgen,undefined
[11] BioPharmaceuticals R&D,undefined
[12] AstraZeneca,undefined
[13] BioPharmaceuticals R&D,undefined
[14] AstraZeneca,undefined
[15] BioPharmaceuticals R&D,undefined
[16] AstraZeneca,undefined
[17] BioPharmaceuticals Medical,undefined
[18] AstraZeneca,undefined
来源：
Respiratory Research | / 21卷
关键词：
Clinical trial; Severe asthma; Tezepelumab; Thymic stromal lymphopoietin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ANAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES
    Yang, H. K.
    Lee, S. H.
    Min, K. W.
    Park, S. W.
    Chung, C. H.
    Park, K. S.
    Choi, S. H.
    Song, K. -H.
    Kim, D. -M.
    Lee, M. -K.
    Sung, Y. A.
    Baik, S. H.
    Kim, I. J.
    Cha, B. -S.
    Park, J. H.
    Ahn, Y. B.
    Lee, I. -K.
    Yoo, S. -J.
    Kim, J. T.
    Park, I. B.
    Park, T. S.
    Yoon, K. -H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S149 - S150
  • [42] The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study
    Gerhard Gerhardsen
    Anne V. Hansen
    Marianne Killi
    Gitte Gleerup Fornitz
    Frank Pedersen
    Signe Barfod Roos
    Advances in Therapy, 2008, 25
  • [43] A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation
    Yiannakou, Yan
    Piessevaux, Hubert
    Bouchoucha, Michel
    Schiefke, Ingolf
    Filip, Rafal
    Gabalec, Libor
    Dina, Ion
    Stephenson, David
    Kerstens, Rene
    Etherson, Kevin
    Levine, Amy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (05): : 741 - 748
  • [44] Secukinumab in Giant Cell Arteritis: A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase 2 Trial
    Venhoff, Nils
    Schmidt, Wolfgang
    Bergner, Raoul
    Rech, Juergen
    Unger, Leonore
    Tony, Hans-Peter
    Mendelson, Meryl
    Sieder, Christian
    Maricos, Meron
    Thiel, Jens
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 4130 - 4133
  • [45] SECUKINUMAB IN GIANT CELL ARTERITIS: THE RANDOMISED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE PHASE 2 TITAIN TRIAL
    Venhoff, N.
    Schmidt, W. A.
    Bergner, R.
    Rech, J.
    Unger, L.
    Tony, H. P.
    Mendelson, M.
    Sieder, C.
    Maricos, M.
    Thiel, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 121 - 122
  • [46] Multicenter, randomized, double-blind, placebo-controlled, parallel trial comparing the safety and efficacy of rufinamide
    Biton, V
    Rosenfeld, W
    Schachter, S
    Perdomo, C
    Arroyo, S
    ANNALS OF NEUROLOGY, 2005, 58 : S114 - S114
  • [47] Efficacy of resveratrol in the treatment of unipolar depression: double-blind randomized placebo-controlled parallel-group study
    Aftanas, L. I.
    Markov, A. A.
    Rikita, M. V.
    Danilenko, K. V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S189 - S189
  • [48] Effect of Tezepelumab on Airway Inflammation in Patients with Moderate-to-Severe Uncontrolled Asthma: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study (CASCADE)
    Diver, S. E.
    Khalfaoui, L.
    Emson, C.
    Wenzel, S. E.
    Menzies-Gow, A.
    Wechsler, M.
    Johnston, J.
    Downie, J.
    Parnes, J. R.
    Megally, A.
    Colice, G.
    Brightling, C. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [49] Efficacy and Safety of Bempedoic Acid for Hypercholesterolemia in Japan: A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Trial
    Yamashita, Shizuya
    Fujita, Hitomi
    Yokota, Daisuke
    Morikawa-Isogai, Yuki
    Kitamoto, Ryuki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2025,
  • [50] Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
    Pavord, Ian D.
    Korn, Stephanie
    Howarth, Peter
    Bleecker, Eugene R.
    Buhl, Roland
    Keene, Oliver N.
    Ortega, Hector
    Chanez, Pascal
    LANCET, 2012, 380 (9842): : 651 - 659
12345